Neuroimmunomodulatory effects of morphine in Leishmania donovani-infected hamsters

NeuroImmunoModulation

Volumn 10, Issue 5, 2002, Pages 261-269

  Singal, Priya ^a,b   Kinhikar, Arvind G ^a   Singh, Savita ^a   Singh, Prati Pal ^a  

^a Natl Inst Pharmaceutical Educ R   (India)

^b National Institute of Pharmaceutical Education and Research   (India)

Author keywords

Hamsters; Leishmania donovani; Macrophages; Morphine; Neuroimmunomodulation

Indexed keywords

MORPHINE; NALOXONE; OPIATE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL COUNT; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG MEGADOSE; DRUG POTENTIATION; FEMALE; HAMSTER; HOST RESISTANCE; IMMUNOMODULATION; LEISHMANIA DONOVANI; LEUKOCYTE; LOW DRUG DOSE; MACROPHAGE; MALE; MICROSCOPY; MONOCYTE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTOZOAL INFECTION; SPLEEN; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CRICETINAE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNOSUPPRESSIVE AGENTS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MACROPHAGES; MALE; MESOCRICETUS; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NEUROIMMUNOMODULATION; PHAGOCYTOSIS; RECEPTORS, OPIOID; TREATMENT OUTCOME;

EID: 0038693578     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069970     Document Type: Article

References (46)

1. Gomez-Flores R, Weber RJ: Opioids, opioid receptors, and the immune system; in Plotnikoff N, Faith R, Murguo A, Good R (eds): Cytokines: Stress and Immunity. Boca Raton, CRC, 1999, pp 281-314.
2. Risdahl JM, Khanna KV, Peterson PK, Molitor TW: Opiates and infection. J Neuroimmunol 1998;83:4-18.
3. Rojavin M, Szabo I, Bussiere JL, Rogers TJ, Adler MW, Eisenstein TK: Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sci 1993;53:997-1006.
4. Gomez-Flores R, Suo J-L, Weber RJ: Suppression of splenic macrophage functions following acute morphine action in the rat mesencephalon periaqueductal gray. Brain Behav Immun 1999;13:212-224.
5. Gomez-Flores R, Weber RJ: Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray. Immunopharmacology 2000;48:145-156.
6. Handman E, Burgess AW: Stimulation by granulocyte-macrophage colony-stimulating factor of Leishmania tropica killing by macrophages. J Immunol 1979;122:1134-1137.
7. Wieser WY, Van Niel A, Clark SC, David JR, Remold HG: Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages. J Exp Med 1987;166:1436-1440.
8. Risdahl JM, Peterson PK, Chao CC, Pijoan C, Molitor TW: Effects of morphine dependence on the pathogenesis of swine herpes virus infection. J Infect Dis 1993;167:1281-1287.
9. Pacifici R, Patrini G, Venier I, Parolaro D, Zuccaro P, Gori E: Effect of morphine and methadone acute treatment on immunological activity in mice: Pharmacokinetic and pharmacodynamic correlates. J Pharmacol Exp Ther 1994;269:1112-1116.
10. Singh PP, Singh S, Dutta GP, Srimal RC: Immunomodulation by morphine in Plasmodium berghei-infected mice. Life Sci 1994;54:331-339.
11. Rouveix B, Veyries ML: Effects of morphine on murine infection with Friend retrovirus (in French). Bull Acad Natl Med 1995;179:1069-1080.
12. Veyries ML, Sinet M, Desforges B, Rouveix B: Effects of morphine on the pathogenesis of murine Friend retrovirus infection. J Pharmacol Exp Ther 1995;272:498-504.
13. Peterson PK, Molitor TW, Chao CC: The opioid-cytokine connection. J Neuroimmunol 1998;83:63-69.
14. Roy S, Barke RA, Loh HH: Mu-opioid receptor-knockout mice: Role of mu-opioid receptor in morphine mediated immune functions. Brain Res Mol Brain Res 1998;61:190-194.
15. Gomez-Flores R, Weber RJ: Inhibition of interleukin-2 production and downregulation of IL-2 and transferrin receptors on rat splenic lymphocytes following PAG morphine administration: A role in natural killer and T cell suppression. J Interferon Cytokine Res 1999;19:625-630.
16. Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, Morris HR: Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 1975;258:577-579.
17. Hucklebridge FH, Hudspith BN, Lydyard PM, Brostoff J: Stimulation of human peripheral lymphocytes by methionine enkephalin and γ-selective opioid analogues. Immunopharmacology 1990;19:87-91.
18. House RV, Thomas PT, Bhargava HM: A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides. Peptides 1996;17:75-81.
19. Foris G, Medgyesi GA, Hauck M: Bidirectional effect of met-enkephalin on macrophage effector functions. Mol Cell Biochem 1986;69:127-137.
20. Cameron DJ: Effect of neuropeptides on macrophage mediated cytotoxicity in normal donors and cancer patients. Jpn J Exp Med 1987;57:31-39.
21. Nowak JE, Gomez-Flores R, Calderon SN, Rice KC, Weber RJ: Rat natural killer cell, T cell, and macrophage functions after intracerebroventricular injection of SNC 80. J Pharmacol Exp Ther 1998;286:931-937.
22. Kowalski J: Augmenting effects of opioids on nitrite production by stimulated murine macrophages. Neuropeptides 1998;32:287-291.
23. Iuvone T, Capasso A, D'Acquisto F, Carnuccio R: Opioids inhibit the induction of nitric oxide synthase in J774 macrophages. Biochem Biophys Res Commun 1995;212:957-980.
24. Sazbo I, Rojavin M, Bussiere JL, Eisenstein TK, Adler MW, Rogers TJ: Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J Pharmacol Exp Ther 1993;267:703-706.
25. Singh PP, Singh S, Dhawan VC, Haq W, Mathur KB, Dutta GP, Srimal RC, Dhawan BN: Enkephalins-modulation ofPlasmodium cynomolgiantigens-induced colony-stimulating factors elaboration by macrophages. J Biol Regul Homeost Agents 1991;5:142-146.
26. Singh S, Singh PP, Dhawan VC, Haq W, Mathur KB, Dutta GP, Srimal RC, Dhawan BN: Lymphokines production by concanavalin A-stimulated mouse splenocytes: Modulation by Met-enkephalin and a related peptide. Immunopharmacology 1994;27:245-251.
27. Stauber A: Host resistance to the Khartoum strain of Leishmania donovani. Rice Inst Pamphlets 1958;45:80-96.
28. Singh PP, Dutta GP: Simian malaria-induced lymphokines: Enhancement of macrophage erythrophagocytosis. Indian J Parasitol 1989;13:281-293.
29. Tubaro E, Borelli G, Croce C, Cavallo G, Santiangelli C: Effect of morphine on resistance to infection. J Infect Dis 1983;148:656-666.
30. Bryant HU, Bernton EW, Holaday JW: Immunomodulatory effects of chronic morphine treatment: Pharmacological and mechanistic studies. NIDA Res Monogr 1990;96:131-149.
31. Carr DJ, Rogers TJ, Weber RJ: The relevance of opioids and opioid receptors on immunocompetence and immune homoestasis. Proc Soc Exp Biol Med 1996;213:248-257.
32. Suo JL, Weber RJ: Immunomodulation mediated by microinjection of morphine into the periaqueductal gray matter of the mesencephalon. Adv Exp Med Biol 1998;437:177-182.
33. Singh S, Singh PP: Morphine modulation of plasmodial-antigens-induced colony-stimulating factors production by macrophages. Life Sci 2000;67:1035-1045.
34. Greil J, Bodendorfer B, Rollinghoff M, Solbach W: Application of recombinant granulocyte-macrophage colony stimulating factor has detrimental effects in experimental murine leishmaniasis. Eur J Immunol 1988;18:1527-1533.
35. Hockmeyer WT, Walters D, Gore RW, Williams JS, Fortier AH, Nacy CA: Intracellular destruction of Leishmania donovani and Leishmania tropica amastigotes by activated macrophages: Dissociation of these microbicidal effector activities in vitro. J Immunol 1984;132:3120-3125.
36. Kimes AS, Smith WJ, Winchell CJ, London ED: Effect of morphine on the phenotypic expression of cell surface markers on murine lymphocytes. Life Sci 1992;51:807-815.
37. Yeager MP, Yu CT, Campbell AS, Moschella M, Guyre PM: Effect of morphine and beta-endorphin on human Fc receptor-dependent and natural killer cell functions. Clin Immunol Immunopathol 1992;62:336-343.
38. Roy S, Loh HH: Effects of the opioids on the immune system. Neurochem Res 1996;21:1373-1384.
39. Sharp BM, Roy S, Bidlack JM: Evidence for opioid receptors on cells involved in host defense and the immune system. J Neuroimmunol 1998;83:45-56.
40. Hall DM, Suo J-L, Weber RJ: Opioid mediated effects on the immune system: Sympathetic nervous system involvement. J Immunol 1998;83:29-35.
41. Stefano GB: Autoimmunovascular regulation: Morphine and anandamide and ancondamide stimulated nitric oxide release. J Neuroimmunol 1998;83:70-76.
42. Stefano GB, Salzet M, Rialas C, Mattocks DW, Fimiani C, Bilfinger TV: Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: Endothelial implications. Int J Cardiol 1998;64:S3-S13.
43. Chao CC, Sharp BM, Pomeroy C, Filice GA, Peterson PK: Lethality of morphine in mice infected with Toxoplasma gondii. J Pharmacol Exp Ther 1990;252:605-609.
44. MacFarlane AS, Peng X, Miessler JJ Jr, Rogers TJ, Geller EB, Adler MW, Eisenstein TK: Morphine increases susceptibility to oral Salmonella typhimurium infection. J Infect Dis 2000;181:1350-1358.
45. Specter S, Plotnikoff N, Bradely WG, Goodfellow D: Methionine enkephalin combined with AZT therapy reduce murine retrovirus-induced disease. Int J Immunopharmacol 1994;16:911-917.
46. Tang J-L, Lipkowski AW, Specter S: Inhibitory effect of biphalin and AZT on murine Friend leukemia virus infection in vitro. Int J Immunopharmacol 1998;20:457-466.